Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
69 studies found for:    Northwestern AND Genetic Testing
Show Display Options
Rank Status Study
1 Completed 4R for Guideline Indicated BRCA Testing of Breast Center Patients
Conditions: Newly Diagnosed Carcinoma of Breast;   Genetic Predisposition to Disease
Intervention:
2 Completed Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting
Conditions: Colon Cancer;   Lynch Syndrome
Intervention: Procedure: MSI screening test
3 Recruiting A Prospective Study of Breast Cancer Patients With Abnormal Strain Imaging
Conditions: HER2 Positive Breast Cancer;   Cardiovascular Abnormalities
Intervention: Drug: Carvedilol
4 Recruiting Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Conditions: Large Cell Lung Carcinoma;   Lung Adenocarcinoma;   Stage IB Non-Small Cell Lung Carcinoma;   Stage IB Squamous Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIA Squamous Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIB Squamous Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIA Squamous Cell Lung Carcinoma
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
5 Recruiting NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma
Conditions: Advanced Malignant Solid Neoplasm;   Lymphoma;   Recurrent Malignant Solid Neoplasm;   Recurrent Plasma Cell Myeloma;   Refractory Malignant Neoplasm;   Refractory Plasma Cell Myeloma
Interventions: Drug: Afatinib;   Drug: Akt inhibitor AZD5363;   Drug: Binimetinib;   Drug: Crizotinib;   Other: Cytology Specimen Collection Procedure;   Drug: Dabrafenib;   Drug: Dasatinib;   Drug: Defactinib;   Drug: FGFR Inhibitor AZD4547;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Drug: Osimertinib;   Drug: Palbociclib;   Biological: Pertuzumab;   Drug: PI3K-beta Inhibitor GSK2636771;   Drug: Sapanisertib;   Drug: Sunitinib Malate;   Drug: Taselisib;   Drug: Trametinib;   Biological: Trastuzumab Emtansine;   Drug: Trk Inhibitor LOXO-101;   Drug: Vismodegib;   Drug: WEE1 Inhibitor AZD1775
6 Enrolling by invitation Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management
Conditions: Pain;   Chronic Pain;   Back Pain;   Nociceptive Pain;   Neuropathic Pain;   Musculoskeletal Pain;   Neck Pain;   Pain, Intractable
Intervention: Other: Observational
7 Recruiting Combined Breast Cancer Risk Study
Condition: Hereditary Cancer
Intervention: Diagnostic Test: Diagnostic test
8 Completed Non-invasive Chromosomal Examination of Trisomy Study
Condition: Trisomy 21
Intervention:
9 Recruiting Consent for Use of Stored Patient Specimens for Future Testing
Condition: HIV Infections
Intervention:
10 Recruiting Russian Familial Hypercholesterolemia Registry
Condition: Familial Hypercholesterolemia
Intervention:
11 Unknown  Pharmacogenomic Testing Of the Elderly To Reduce Morbidity
Condition: Genetics of Drug Metabolism
Intervention:
12 Active, not recruiting Clinical Implementation of Carrier Status Using Next Generation Sequencing
Condition: Genetic Disorders
Interventions: Genetic: Whole Genome Sequencing;   Genetic: Carrier status testing
13 Active, not recruiting HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Intervention: Other: None - this is an observational study
14 Recruiting OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Conditions: Eosinophilic Gastrointestinal Disorders (EGIDs);   Eosinophilic Esophagitis;   Eosinophilic Gastritis;   Eosinophilic Colitis
Intervention:
15 Completed Genetic Predisposition-Chronic Nephrotoxicity From CI-Liver Transplant Recipients-Potential Correlation-Urinary Biomarkers
Condition: Complication of Transplanted Liver
Intervention:
16 Recruiting MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Condition: Ductal Breast Carcinoma In Situ
Interventions: Procedure: Magnetic Resonance Imaging;   Procedure: Therapeutic Conventional Surgery;   Procedure: Therapeutic Surgical Procedure;   Radiation: Radiation Therapy;   Drug: Endocrine Therapy;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis;   Other: Cytology Specimen Collection Procedure
17 Active, not recruiting Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Condition: Major Depressive Disorder (MDD)
Intervention: Genetic: GeneSight Psychotropic
18 Recruiting Effects of Thymoglobulin on Human B Cells
Conditions: Acute Humoral Rejections;   Chronic Humoral Rejections;   Transplant
Intervention: Procedure: Blood Draws
19 Recruiting Classification of Heart Failure With Preserved Ejection Fraction
Conditions: Heart Failure With Preserved Ejection Fraction;   Diastolic Heart Failure
Intervention:
20 Recruiting Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease
Condition: Arthritis, Rheumatoid
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.